Literature DB >> 32212895

Response by Dula et al to Letter Regarding Article, "Neuroimaging in Ischemic Stroke Is Different Between Men and Women in the DEFUSE 3 Cohort".

Adrienne N Dula1, Michael Mlynash2, Gregory W Albers2, Steven J Warach1.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32212895      PMCID： PMC7188570          DOI： 10.1161/STROKEAHA.120.029168

Source DB:  PubMed          Journal:  Stroke        ISSN： 0039-2499            Impact factor:   7.914


× No keyword cloud information.
  3 in total

1.  Collateral Status on Baseline Computed Tomographic Angiography and Intra-Arterial Treatment Effect in Patients With Proximal Anterior Circulation Stroke.

Authors:  Olvert A Berkhemer; Ivo G H Jansen; Debbie Beumer; Puck S S Fransen; Lucie A van den Berg; Albert J Yoo; Hester F Lingsma; Marieke E S Sprengers; Sjoerd F M Jenniskens; Geert J Lycklama À Nijeholt; Marianne A A van Walderveen; René van den Berg; Joseph C J Bot; Ludo F M Beenen; Anna M M Boers; Cornelis H Slump; Yvo B W E M Roos; Robert J van Oostenbrugge; Diederik W J Dippel; Aad van der Lugt; Wim H van Zwam; Henk A Marquering; Charles B L M Majoie
Journal:  Stroke       Date:  2016-01-28       Impact factor: 7.914

2.  Determining factors of better leptomeningeal collaterals: a study of 857 consecutive acute ischemic stroke patients.

Authors:  Stefania Nannoni; Gaia Sirimarco; Carlo W Cereda; Dimitris Lambrou; Davide Strambo; Ashraf Eskandari; Pascal J Mosimann; Max Wintermark; Patrik Michel
Journal:  J Neurol       Date:  2019-01-04       Impact factor: 4.849

3.  Collateral Circulation and Outcome in Atherosclerotic Versus Cardioembolic Cerebral Large Vessel Occlusion.

Authors:  Valeria Guglielmi; Natalie E LeCouffe; Sanne M Zinkstok; Kars C J Compagne; Reyhan Eker; Kilian M Treurniet; Manon L Tolhuisen; H Bart van der Worp; Ivo G H Jansen; Robert J van Oostenbrugge; Henk A Marquering; Diederik W J Dippel; Bart J Emmer; Charles B L M Majoie; Yvo B W E M Roos; Jonathan M Coutinho
Journal:  Stroke       Date:  2019-10-29       Impact factor: 7.914
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.